Epclusa
Gilead Subsidiary to Launch Generic HCV Drugs
The list price of authorized generics to reflect discounts in the system today.
SEPTEMBER 26, 2018
FDA Expands Indication Labeling for Epclusa to Treat Chronic HCV in HIV Coinfected Patients
The FDA approved updated labeling for Epclusa, the first all-oral, pan-genotypic, once-daily single-tablet ...
AUGUST 2, 2017
Load more